You would have to be very careful about the Abilify dosage. Abilify is metabolized by an enzyme, CYP 2D6, both Wellbutrin and Prozac inhibits that enzyme. This will result in increased levels of Abilify.
Anti enzymes or enzyme inhibitors, are substances which inhibit counteracts the action of an enzyme.
Substances that inhibit the production or the action of transcriptase, which is an enzyme.
The method of enzyme control where the products of a reaction inhibit the enzyme by binding to it is known as feedback inhibition. In this process, the end product of a metabolic pathway binds to an enzyme involved in the pathway, reducing its activity and preventing the overproduction of the product. This regulatory mechanism helps maintain homeostasis and balance within the cell.
A substrate effector is a molecule that can bind to an enzyme's substrate and either enhance or inhibit the enzyme's activity. This can influence the rate of the enzyme-catalyzed reaction.
Inorganic phosphate can inhibit enzyme activity by competing with the substrate for the enzyme's active site. This can prevent the substrate from binding to the enzyme and undergoing the catalytic reaction. Additionally, inorganic phosphate may alter the enzyme's conformation, affecting its ability to catalyze the reaction.
A noncompetitive enzyme inhibitor works by binding to the enzyme at a site other than the active site, causing a change in the enzyme's shape. This change makes it harder for the substrate to bind to the enzyme, reducing its activity.
they inhibit the enzyme Acetylcholinesterase (AChE) allowing Acetylcholine (ACh) to accumulate.
If an enzyme has been inhibited noncompetitively, the inhibitor binds to the enzyme at a site other than the active site, altering the enzyme's shape and reducing its activity. This type of inhibition is not overcome by increasing the substrate concentration.
The fructose-1-phosphate inhibits gluconeogenesis through the enzyme aldolase.
Copper(II) sulfate is an inhibitor of enzyme activity. It can denature proteins by disrupting the secondary and tertiary structures of enzymes, leading to a loss of their function. Additionally, it can inhibit enzyme activity by interfering with the binding of substrates to the active site of the enzyme.
With regard to pharmacokinetics, methadone is primarily metabolized by the CYP3A4 enzyme and to a lesser degree by CYP2B6. Medications that induce or inhibit this enzyme(which Lidocaine is one) can increase or decrease the serum concentrations of methadone.